Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure

ClinicalTrials.gov ID: NCT00259038

Public ClinicalTrials.gov record NCT00259038. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 1:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Dose Escalation Evaluation of the Pharmacokinetic and Hemodynamic Effects of Carperitide in Subjects With Congestive Heart Failure

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study will evaluate the safety and efficacy of intravenous infusion of carperitide using pressure measurements inside the heart and great vessels and measuring carperitide concentration in the blood.

Study identification

NCT ID
NCT00259038
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Daiichi Sankyo
Industry
Enrollment
162 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2004 (Type not available)
Primary completion
Feb 2006 (Actual)
Completion
Feb 2006 (Actual)
Last update posted
Nov 8, 2016

2004 – 2006

United States locations

U.S. sites
30
U.S. states
16
U.S. cities
28
Facility City State ZIP Site status
Not listed Huntsville Alabama 35801 —
Not listed Los Angeles California 90033 —
Not listed Orange California 92868 —
Not listed San Diego California 92103 —
Not listed Bay Pines Florida 33744 —
Not listed Gainesville Florida 32610 —
Not listed Jacksonville Florida 32216 —
Not listed Miami Florida 33136 —
Not listed Orlando Florida 32803 —
Not listed St. Petersburg Florida 33707 —
Not listed Chicago Illinois 60611 —
Not listed Chicago Illinois 60612 —
Not listed Springfield Illinois 62701 —
Not listed Covington Louisiana 70433 —
Not listed Shreveport Louisiana 71103 —
Not listed Baltimore Maryland 21201 —
Not listed Minneapolis Minnesota 55455 —
Not listed St Louis Missouri 63110 —
Not listed Albany New York — —
Not listed Cincinnati Ohio 45267 —
Not listed Cleveland Ohio 44195 —
Not listed Tulsa Oklahoma — —
Not listed Charleston South Carolina — —
Not listed Columbia South Carolina — —
Not listed Amarillo Texas 79106 —
Not listed Houston Texas 77030 —
Not listed Houston Texas 77225 —
Not listed Richmond Virginia 23298 —
Not listed Tacoma Washington 98405 —
Not listed Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00259038, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 8, 2016 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00259038 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →